ChemoCentryx

The Best- And Worst-Performing Biotech Stocks, June 28 to July 5
Forbes
Mon, 07/8/13 - 11:02 am
biotech
ONYX Pharmaceuticals
Celldex
Novavax
Puma Biotechnology
Endocyte
Alnylam
Bluebird Bio
Dyax
Medivation
Clovis Oncology
Achillion
Insmed
Arena Pharmaceuticals
Avanir
Receptos
Synergy Pharmaceuticals
ChemoCentryx
Idenix
MiMedx
Portola Pharmaceuticals
Biotech Stock Mailbag: 2013 Clinical Trials Calendar
TheStreet.com
Fri, 06/7/13 - 08:41 am
Zerenex
Xoma
Vical
Takeda
sovaprevir
Soluble Ferric Pyrophosphate
Rockwell Medical
Orexigen
MM-398
Merrimack Pharmaceuticals
MannKind
Keryx
GTx
GSK
gevokizumab
enobosarm
Coronado Biosciences
Contrave
CNDO-201
clinical trials
ChemoCentryx
CCX140
Biodel
BIOD-123
Amigal
Amicus Therapeutics
Alnylam
ALN-TTR02
Allovectin
Afrezza
Achillion
ACH-3102
5 Healthcare Companies With Insider Buying During November 2012 - Part III
Seeking Alpha
Sat, 11/10/12 - 08:21 am
Corcept Therapeutics
ChemoCentryx
GSK
Valeant Pharmaceuticals
HealthSouth
6 Biotech Stocks That Could Be In For A Short Squeeze
Seeking Alpha
Mon, 08/20/12 - 11:38 am
Aveo Pharmaceutical
BioTime
ChemoCentryx
Optimer Pharmaceuticals
Clovis Oncology
PDL Biopharma
8 Intriguing Small Cap Biotechnology Companies For Your Consideration
Seeking Alpha
Mon, 08/20/12 - 10:32 am
Affymax
Alnylam
Arena Pharmaceuticals
Aveo
BioTime
ChemoCentryx
Emergent BioSolutions
Clovis Oncology
Enzon
Forest Labs
Geron
ViroPharma
Targacept
GSK
Pfizer
Santarus
PDL Biopharma
Infinity Pharmaceuticals
Nektar
22 Biopharma Stocks With Breakout Potential in 2012
Seeking Alpha
Tue, 05/22/12 - 11:25 am
Ziopharm
Zalicus
EXACT Sciences
Geron
Lexicon Pharmaceuticals
Nektar
Vical
Celgene
Celsion
ChemoCentryx
Clovis Oncology
Eli Lilly
JNJ
Pfizer
Elan
Biomarin
Biogen Idec
Auxilium
Arqule
Anthera
Acadia
Amicus Therapeutics
Vertex Pharmaceuticals
ChemoCentryx refiles IPO plans, looks to raise $69M
Mon, 10/17/11 - 10:29 pm
ChemoCentryx
IPO
fundraising
ChemoCentryx attempts oral autoimmune drug
Fierce Biotech
Thu, 11/4/10 - 11:37 am
ChemoCentryx
autoimmune disease
Glaxo Exercises Drug Option
Yahoo/Zacks.com
Tue, 01/12/10 - 08:58 pm
GSK
licensing
Merck
Bristol-Myers Squibb
ChemoCentryx

Pages